内镜下经蝶垂体肿物切除术后鼻中隔黏膜瓣使用的预测因素
这项回顾性病例对照研究纳入2009年1月起单中心238例内镜下经蝶垂体腺瘤切除术患者,其中39例使用鼻中隔黏膜瓣(NSF)重建。肿瘤大小和解剖特征是可预测NSF使用的因素,肿瘤经蝶鞍延伸者需NSF的比值高6.3倍,冠状位T1 MRI肿瘤高度每增加1毫米NSF使用比值增加1.2。瓣风险评分(FRS)>35时对瓣放置的特异度为87%、灵敏度为85%。
要点
- 肿瘤经蝶鞍延伸者需NSF的比值高6.3倍。
- 冠状位T1 MRI肿瘤高度每增加1毫米,NSF使用比值增加1.2。
- FRS>35时对瓣放置的特异度87%、灵敏度85%。
核心结论
- 术前影像特征可预测NSF使用,FRS可供手术团队和转诊医生判断哪些患者更可能接受NSF重建。
研究设计与样本
- 回顾性病例对照研究,纳入2009年1月起单中心所有内镜下经蝶垂体腺瘤切除术患者,共238例,其中39例接受NSF放置。
主要发现
- 肿瘤大小和 anatomic 特征是病例组与对照组之间显著差异的主要因素。
- 肿瘤经蝶鞍延伸者需NSF的比值高6.3倍。
- 冠状位T1 MRI肿瘤高度每增加1毫米,NSF使用比值增加1.2。
- FRS计算方式为肿瘤高度(毫米)加6(若存在经蝶鞍延伸)。
- FRS>35时对瓣放置的特异度为87%、灵敏度为85%。
关键数值与推荐
- FRS>35时对瓣放置的特异度为87%、灵敏度为85%。
- 肿瘤经蝶鞍延伸者需NSF的比值高6.3倍。
- 冠状位T1 MRI肿瘤高度每增加1毫米,NSF使用比值增加1.2。
- FRS计算方式为肿瘤高度(毫米)加6(若存在经蝶鞍延伸)。
临床怎么用
- 作者认为FRS可供手术团队和转诊医生应用,以判断哪些患者更可能接受NSF重建。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The pedicled nasoseptal flap (NSF) is the widely accepted reconstructive technique of choice for repair of larger skull base defects after endoscopic endonasal approaches. There is a dearth of literature examining the decision-making process regarding flap harvest. The objective of this study is to evaluate preoperative characteristics that predict the use of NSF reconstruction after endoscopic transsphenoidal resection of pituitary tumors. METHODS: In this retrospective case control study, demographic, clinical, imaging, and procedural details were gathered on all patients undergoing endoscopic transsphenoidal pituitary adenoma resection at a single academic center since January 2009. Characteristics were compared for patients receiving an NSF and those not undergoing NSF repair. A multivariate model that best predicted the use of an NSF was built and a risk score was developed. RESULTS: Two hundred thirty-eight patients were included, and 39 underwent NSF placement. Tumor size and anatomic characteristics were the predominant factors that significantly differed between cases and controls. Patients with transsellar tumor extension had 6.3 higher odds of requiring NSF, each millimeter increase in tumor height on coronal T1 magnetic resonance imaging increased the odds of NSF use by 1.2. The flap risk score (FRS) is calculated by adding tumor height (mm) to 6 if there is transsellar extension. At an FRS of >35, the FRS is 87% specific and 85% sensitive for flap placement. CONCLUSIONS: Preoperative imaging characteristics can predict NSF use. The FRS can be applied by surgical teams and referring physicians to determine which patients are more likely to undergo NSF repair.
引用
- Rotman LE, Kicielinski KP, Broadwater DR, et al. Predictors of Nasoseptal Flap Use After Endoscopic Transsphenoidal Pituitary Mass Resection. World Neurosurg. 2018. PMID: 30599246. doi:10.1016/j.wneu.2018.12.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。